Alzamend Neuro Inc.

NASDAQ: ALZN · Real-Time Price · USD
2.40
0.02 (1.05%)
At close: Aug 18, 2025, 2:57 PM

Alzamend Neuro Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Net Income
-1.14M -985.78K -1.42M -974.41K -851.53K -2.66M -2.91M -3.53M -3.31M -5.43M -3.11M -3.04M -3.87M -2.57M -3.6M -2.32M -1.26M -1.12M -1.35M -1.32M
Depreciation & Amortization
12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 5.32K 5.32K 5.32K 7.1K 3.55K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
81.28K 81.28K 81.28K 81.28K 81.28K 186.64K 318.34K 369.38K 491.33K 1.51M 715.64K 867.34K 1.26M 1.13M 1.28M 739.62K 296.86K 575.13K 654.36K 506.01K
Other Working Capital
356.78K -531.82K 184.58K -184.58K -669.85K 431.43K 1.06M 129.23K -1.27M 2.1M 44.72K -237.82K 289.1K -256.84K 248.55K -216.17K 2.01M -259.05K 291.79K 520.22K
Other Non-Cash Items
n/a n/a -2.26M 9.29K 107.36K 1.58M -142.6K -129.23K 2.35M n/a 726.28K 881.53K -4K -16.85K 24.83K 4.79K 407.52K -3.33K -34.98K 85.42K
Deferred Income Tax
n/a n/a n/a n/a 1.3M -1.58M 142.6K 129.23K -2.35M n/a -726.28K -881.53K n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
356.78K -531.82K 184.58K -184.58K -669.85K 431.43K 1.06M -152.5K 573.7K 2.1M 44.72K -374.05K 1.05M -323.88K 248.55K 352.79K -705.42K -259.05K 291.79K 520.22K
Operating Cash Flow
-688.71K -1.42M -3.4M -1.06M -1.43M -2.03M -1.51M -3.3M -2.24M -1.81M -2.34M -2.54M -1.56M -1.78M -2.05M -1.22M -1.26M -806.13K -442.93K -205.1K
Capital Expenditures
-210K n/a 90K -90K 147.24K n/a n/a -147.24K n/a n/a n/a n/a -106.46K n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.37M n/a n/a 4.8M n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -90K n/a n/a n/a n/a -147.24K n/a n/a n/a n/a -5.37M n/a n/a n/a 4.08K n/a n/a 100.92K
Investing Cash Flow
-210K n/a n/a -90K 147.24K n/a n/a -147.24K n/a n/a n/a n/a -106.46K n/a n/a 4.8M 4.08K n/a n/a 100.92K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 40K 285.1K 77.01K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a -87.38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
600.00 87.38K 1.17M n/a 1.52M 1.15M 18.09K n/a 200.00 n/a n/a n/a 3.94M 400.00 700.00 100.00 1.05M 801.01K 100.57K n/a
Financial Cash Flow
1.49M 688.7K 6.3M 1.96M 1.52M 2.11M 18.09K n/a 200.00 n/a n/a n/a 3.94M 400.00 700.00 14.91M 3.15M 841.01K 385.67K 77.01K
Net Cash Flow
590.52K -734.94K 2.9M 817.9K 93.18K 82.79K -1.5M -3.45M -2.23M -1.81M -2.34M -2.54M 2.27M -1.78M -2.05M 13.69M 1.89M 34.88K -57.25K -27.17K
Free Cash Flow
-898.71K -1.42M -3.31M -1.15M -1.28M -2.03M -1.51M -3.45M -2.24M -1.81M -2.34M -2.54M -1.67M -1.78M -2.05M -1.22M -1.26M -806.13K -442.93K -205.1K